In Brief: Boston Scientific
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific: Revenues and operating results for the third quarter will "likely be flat or modestly up from the second quarter" due to "a more significant seasonal slow down in [medical] procedures worldwide than was expected," the firm announces Sept. 4. Due to the relatively lackluster third quarter, revenues and earnings for the year ending Dec. 31 "will likely be below the consensus of analysts' expectations," the firm states...